C07K 5/06008
With the first amino acid being neutral
Official title: {with the first amino acid being neutral}
C07K5/06008 (With the first amino acid being neutral) appears on 2,438 US grants and 2,115 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,438
- Published applications
- 2,115
- Assignees
- 1,219
- Inventors
- 6,465
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 10 | 0 |
| 1978 | 18 | 0 |
| 1979 | 19 | 0 |
| 1980 | 16 | 0 |
| 1981 | 18 | 0 |
| 1982 | 15 | 0 |
| 1983 | 18 | 0 |
| 1984 | 27 | 0 |
| 1985 | 31 | 0 |
| 1986 | 21 | 0 |
| 1987 | 29 | 0 |
| 1988 | 35 | 0 |
| 1989 | 37 | 0 |
| 1990 | 30 | 0 |
| 1991 | 28 | 0 |
| 1992 | 39 | 0 |
| 1993 | 51 | 0 |
| 1994 | 34 | 0 |
| 1995 | 47 | 0 |
| 1996 | 70 | 0 |
| 1997 | 94 | 0 |
| 1998 | 103 | 0 |
| 1999 | 83 | 0 |
| 2000 | 80 | 0 |
| 2001 | 73 | 11 |
| 2002 | 87 | 81 |
| 2003 | 70 | 97 |
| 2004 | 48 | 78 |
| 2005 | 50 | 101 |
| 2006 | 53 | 88 |
| 2007 | 58 | 75 |
| 2008 | 48 | 63 |
| 2009 | 45 | 67 |
| 2010 | 49 | 91 |
| 2011 | 48 | 81 |
| 2012 | 41 | 74 |
| 2013 | 64 | 95 |
| 2014 | 68 | 88 |
| 2015 | 77 | 105 |
| 2016 | 86 | 112 |
| 2017 | 68 | 92 |
| 2018 | 72 | 102 |
| 2019 | 69 | 74 |
| 2020 | 59 | 69 |
| 2021 | 53 | 87 |
| 2022 | 41 | 73 |
| 2023 | 35 | 78 |
| 2024 | 45 | 93 |
| 2025 | 47 | 79 |
| 2026 | 25 | 61 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Molecules18 Aug 2026US 12,709,596 B2Ena Respiratory Pty Ltd
- Linker, antibody-drug conjugate including same and use thereof30 Jun 2026US 12,668,573 B2Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
- Novel hemiasterlin derivative and use thereof10 Sep 2026US 2026/0263616 A1Pinotbio, Inc.
- Method for producing o-substituted serine derivative27 Aug 2026US 2026/0250241 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Peptide nucleic acids763US 5,539,082 A1996
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility543US 5,714,331 A1998
- Methods for identifying RNA binding compounds220US 6,503,713 B1University of Medicine and Dentistry of New Jersey · 2003
- Aminoacid derivatives and their therapeutic applications196US 4,513,009 ASociete Civile Bioprojet · 1985